Cite
HARVARD Citation
Ogata, A. et al. (n.d.). Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis1. Arthritis care & research. 66 (3), pp. 344-354. [Online].